28.12.2016 Views

Global Hormone Replacement Therapy Market estimated to be growing at a CAGR of 7.21%. by 2021

Global Hormone Replacement Therapy Industry report 2016-2021 at Marketdataforecast.com gives a comprehensive account of the Immunoassays market by Hormone Type , Route of Administration and Region

Global Hormone Replacement Therapy Industry report 2016-2021 at Marketdataforecast.com gives a comprehensive account of the Immunoassays market by Hormone Type , Route of Administration and Region

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

RESEARCH REPORT<br />

DEC 2016<br />

GLOBAL HORMONE REPLACEMENT<br />

THERAPY MARKET<br />

SEGMENTED BY TYPE AND ROUTE OF ADMINISTRATION,<br />

INDUSTRY ANALYSIS, SIZE, SHARE, GROWTH TRENDS AND<br />

FORECASTS 2016-<strong>2021</strong>


<strong>Global</strong> <strong>Hormone</strong> <strong>Replacement</strong> <strong>Therapy</strong> <strong>Market</strong><br />

According <strong>to</strong> the report "<strong>Hormone</strong> <strong>Replacement</strong> <strong>Therapy</strong> <strong>Market</strong>”, published <strong>by</strong> <strong>Market</strong> D<strong>at</strong>a Forecast, the<br />

global market is projected <strong>to</strong> reach USD 22.31 billion <strong>by</strong> <strong>2021</strong>, <strong>at</strong> a <strong>CAGR</strong> <strong>of</strong> <strong>7.21%</strong> from 2016 <strong>to</strong> <strong>2021</strong>.<br />

View Report <strong>at</strong> http://www.marketd<strong>at</strong>aforecast.com/market-reports/global-hormone-replacementtherapy-market-957/<br />

<strong>Hormone</strong> replacement therapy (HRT) is employed in p<strong>at</strong>ients suffering from declining levels <strong>of</strong> hormones with<br />

the right administr<strong>at</strong>ion <strong>of</strong> hormones in<strong>to</strong> the body. These therapies are generally meted out <strong>to</strong> women<br />

undergoing menopause. Estrogen is among the most commonly administered hormones. However,<br />

progesterone and tes<strong>to</strong>sterone are also administered when needed.<br />

Get free sample report <strong>at</strong> http://www.marketd<strong>at</strong>aforecast.com/market-reports/global-hormonereplacement-therapy-market-957/request-sample<br />

Growing awareness on post-menopausal hazards, reimbursement policies, novel formul<strong>at</strong>ions, rise in unmet<br />

medical needs which require the employment <strong>of</strong> hormone therapy, <strong>be</strong>nefits like lower risk <strong>of</strong> fractures are the<br />

few fac<strong>to</strong>rs propelling the growth <strong>of</strong> global hormone replacement therapy market.<br />

Responsible for more than half <strong>of</strong> the market revenues, the estrogen replacement therapy segment domin<strong>at</strong>es<br />

the global HRT market. The largest consumers <strong>of</strong> estrogen replacement therapy are post-menopausal women.<br />

North America domin<strong>at</strong>ed the market, where the majority <strong>of</strong> the contribution was from the USA owing <strong>to</strong> the<br />

well-established healthcare system. While, the market in the APAC region is expected <strong>to</strong> witness a rapid<br />

growth during the forecast period.<br />

<strong>Global</strong> <strong>Market</strong> for <strong>Hormone</strong> <strong>Replacement</strong> <strong>Therapy</strong> is segmented <strong>by</strong> <strong>Hormone</strong> Type, Route <strong>of</strong><br />

Administr<strong>at</strong>ion and Region<br />

1. By <strong>Hormone</strong> Type<br />

<br />

<br />

<br />

<br />

Estrogen <strong>Replacement</strong> <strong>Therapy</strong><br />

Growth <strong>Hormone</strong> <strong>Replacement</strong> <strong>Therapy</strong><br />

Thyroid <strong>Replacement</strong> <strong>Therapy</strong><br />

Others<br />

2. By Route <strong>of</strong> Administr<strong>at</strong>ion<br />

<br />

<br />

<br />

<br />

Oral<br />

Parenteral<br />

Transdermal<br />

Others<br />

+1 888-702-9626 | www.marketd<strong>at</strong>aforecast.com | contact@marketd<strong>at</strong>aforecast.com


<strong>Global</strong> <strong>Hormone</strong> <strong>Replacement</strong> <strong>Therapy</strong> <strong>Market</strong><br />

3. By Geography<br />

<br />

<br />

<br />

<br />

<br />

North America<br />

Europe<br />

Asia-Pacific<br />

L<strong>at</strong>in America<br />

Middle-East & Africa<br />

Enquire <strong>be</strong>fore buying <strong>at</strong> http://www.marketd<strong>at</strong>aforecast.com/market-reports/global-hormonereplacement-therapy-market-957/inquire<br />

Some <strong>of</strong> the key players oper<strong>at</strong>ing in the hormone replacement industry are Abbott Labora<strong>to</strong>ries, Novartis,<br />

Pfizer, Mylan Labora<strong>to</strong>ries, Amgen, Merck & Co., Bayer, Eli Lily, Novo Nordisk, Wyeth, F. H<strong>of</strong>fmann-La Roche,<br />

Hisamitsu Pharmaceutical Co. Inc.<br />

Buy this report <strong>at</strong> https://www.marketd<strong>at</strong>aforecast.com/cart/buy-now/global-hormone-replacementtherapy-market-957<br />

TABLE OF CONTENTS<br />

1. Introduction<br />

1.1 <strong>Market</strong> Definition<br />

1.2 Study Deliverables<br />

1.3 Base Currency, Base Year and Forecast Periods<br />

1.4 General Study Assumptions<br />

2. Research Methodology<br />

2.1 Introduction<br />

2.2 Research Phases<br />

2.2.1 Secondary Research<br />

2.2.2 Primary Research<br />

2.2.3 Econometric Modelling<br />

2.2.4 Expert Valid<strong>at</strong>ion<br />

2.3 Analysis Design<br />

2.4 Study Timeline<br />

3. Overview<br />

+1 888-702-9626 | www.marketd<strong>at</strong>aforecast.com | contact@marketd<strong>at</strong>aforecast.com


<strong>Global</strong> <strong>Hormone</strong> <strong>Replacement</strong> <strong>Therapy</strong> <strong>Market</strong><br />

3.1 Executive Summary<br />

3.2 Key Inferences<br />

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)<br />

4.1 <strong>Market</strong> Drivers<br />

4.2 <strong>Market</strong> Restraints<br />

4.3 Key Challenges<br />

4.4 Current Opportunities in the <strong>Market</strong><br />

5. <strong>Market</strong> Segment<strong>at</strong>ion<br />

5.1 By <strong>Hormone</strong> Type<br />

5.1.1 Estrogen <strong>Replacement</strong> <strong>Therapy</strong><br />

5.1.2 Growth <strong>Hormone</strong> <strong>Replacement</strong> <strong>Therapy</strong><br />

5.1.3 Thyroid <strong>Replacement</strong> <strong>Therapy</strong><br />

5.1.4 Others<br />

5.2 By Route <strong>of</strong> Administr<strong>at</strong>ion<br />

5.2.1 Oral<br />

5.2.2 Parenteral<br />

5.2.3 Transdermal<br />

5.2.4 Others<br />

Request Cus<strong>to</strong>miz<strong>at</strong>ion <strong>at</strong> http://www.marketd<strong>at</strong>aforecast.com/market-reports/global-hormonereplacement-therapy-market-957/cus<strong>to</strong>mize-report<br />

6. Geographical Analysis<br />

6.1 North America<br />

6.1.1 Introduction<br />

6.1.2 United St<strong>at</strong>es<br />

6.1.3 Canada<br />

6.2 Europe<br />

6.2.1 Introduction<br />

6.2.2 U.K<br />

6.2.3 Spain<br />

6.2.4 Germany<br />

+1 888-702-9626 | www.marketd<strong>at</strong>aforecast.com | contact@marketd<strong>at</strong>aforecast.com


<strong>Global</strong> <strong>Hormone</strong> <strong>Replacement</strong> <strong>Therapy</strong> <strong>Market</strong><br />

6.2.5 Italy<br />

6.3 Asia-Pacific<br />

6.2.6 France<br />

6.3.1 Introduction<br />

6.3.2 China<br />

6.3.3 India<br />

6.3.4 Japan<br />

6.3.5 South Korea<br />

6.3.6 Australia<br />

6.4 L<strong>at</strong>in America<br />

6.4.1 Introduction<br />

6.4.2 Brazil<br />

6.4.3 Argentina<br />

6.4.4 Mexico<br />

6.5 Middle East & Africa<br />

6.5.1 Introduction<br />

6.5.2 Middle-East<br />

6.5.3 Africa<br />

7. Pipeline Product Analysis<br />

7.1 Overview<br />

7.2 Pipeline Development Landscape<br />

7.3 Molecular Targets in the Pipeline<br />

7.4 Clinical Trials<br />

7.4.1 Failure R<strong>at</strong>e <strong>by</strong> Stage <strong>of</strong> Development, Indic<strong>at</strong>ion, Molecule Type and<br />

Molecular Target<br />

7.4.2 Clinical Trial Dur<strong>at</strong>ion <strong>by</strong> Stage <strong>of</strong> Development, Indic<strong>at</strong>ion, Molecule Type<br />

and Molecular Target<br />

7.4.3 Clinical Trial Size <strong>by</strong> Stage <strong>of</strong> Development, Indic<strong>at</strong>ion, Molecule Type and<br />

Molecular Target.<br />

8. Str<strong>at</strong>egic Analysis<br />

8.1 PESTLE analysis<br />

+1 888-702-9626 | www.marketd<strong>at</strong>aforecast.com | contact@marketd<strong>at</strong>aforecast.com


<strong>Global</strong> <strong>Hormone</strong> <strong>Replacement</strong> <strong>Therapy</strong> <strong>Market</strong><br />

8.1.1 Political<br />

8.1.2 Economic<br />

8.1.3 Social<br />

8.1.4 Technological<br />

8.1.5 Legal<br />

8.1.6 Environmental<br />

8.2 Porter’s Five analysis<br />

8.2.1 Bargaining Power <strong>of</strong> Suppliers<br />

8.2.2 Bargaining Power <strong>of</strong> Consumers<br />

8.2.3 Thre<strong>at</strong> <strong>of</strong> New Entrants<br />

8.2.4 Thre<strong>at</strong> <strong>of</strong> Substitute Products and Services<br />

8.2.5 Competitive Rivalry within the Industry<br />

9. <strong>Market</strong> Leaders' Analysis<br />

9.1 Abbott Labora<strong>to</strong>ries<br />

9.1.1 Overview<br />

9.1.2 Product Analysis<br />

9.1.3 Financial analysis<br />

9.1.4 Recent Developments<br />

9.1.5 SWOT analysis<br />

9.1.6 Analyst View<br />

9.2 Novartis<br />

9.3 Pfizer<br />

9.4 Mylan Labora<strong>to</strong>ries<br />

9.5 Amgen<br />

9.6 Merck & Co.<br />

9.7 Bayer<br />

9.8 Eli Lily & Company<br />

9.9 Novo Nordisk<br />

9.10 Wyeth<br />

9.11 F. H<strong>of</strong>fmann-La Roche<br />

9.12 Hisamitsu Pharmaceutical Co. Inc.<br />

+1 888-702-9626 | www.marketd<strong>at</strong>aforecast.com | contact@marketd<strong>at</strong>aforecast.com


<strong>Global</strong> <strong>Hormone</strong> <strong>Replacement</strong> <strong>Therapy</strong> <strong>Market</strong><br />

10. Competitive Landscape<br />

10.1 <strong>Market</strong> share analysis<br />

10.2 Merger and Acquisition Analysis<br />

10.3 Agreements, collabor<strong>at</strong>ions and Joint Ventures<br />

10.4 New Product Launches<br />

11.Expert Opinions<br />

11.1 <strong>Market</strong> Outlook<br />

11.2 Investment Opportunities<br />

Appendix<br />

a) List <strong>of</strong> Tables<br />

b) List <strong>of</strong> Figures<br />

For more rel<strong>at</strong>ed reports from Therapeutics segment:<br />

Au<strong>to</strong>immune Monoclonal Antibodies <strong>Market</strong>: http://www.marketd<strong>at</strong>aforecast.com/marketreports/global-au<strong>to</strong>immune-monoclonal-antibodies-1170/<br />

Cancer Immunotherapy <strong>Market</strong>: http://www.marketd<strong>at</strong>aforecast.com/market-reports/globalcancer-immunotherapy-market-1412/<br />

Cardiovascular Therapeutic Drugs <strong>Market</strong>: http://www.marketd<strong>at</strong>aforecast.com/marketreports/global-cardiovascular-therapeutic-drugs-market-1426/<br />

Cervical Cancer Diagnostics and Therapeutics <strong>Market</strong>:<br />

http://www.marketd<strong>at</strong>aforecast.com/market-reports/global-cervical-cancer-diagnostics-andtherapeutics-market-829/<br />

+1 888-702-9626 | www.marketd<strong>at</strong>aforecast.com | contact@marketd<strong>at</strong>aforecast.com


<strong>Global</strong> <strong>Hormone</strong> <strong>Replacement</strong> <strong>Therapy</strong> <strong>Market</strong><br />

SCOPE OF THE REPORT<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<strong>Global</strong>, regional and country-level analysis and forecasts <strong>of</strong> the study market; providing<br />

Insights on the major countries/regions in which this industry is blooming and <strong>to</strong> also identify<br />

the regions th<strong>at</strong> are still untapped<br />

Segment-level analysis in terms <strong>of</strong> technology, component, and type along with market size<br />

forecasts and estim<strong>at</strong>ions <strong>to</strong> detect key areas <strong>of</strong> industry growth in detail<br />

Identific<strong>at</strong>ion <strong>of</strong> key drivers, restraints, opportunities, and challenges (DROC) in the market<br />

and their impact on shifting market dynamics<br />

Study <strong>of</strong> the effect <strong>of</strong> exogenous and endogenous fac<strong>to</strong>rs th<strong>at</strong> affect the global market; which<br />

includes broadly demographic, economics, and political, among other macro-environmental<br />

fac<strong>to</strong>rs presented in an extensive PESTLE Analysis<br />

Study the micro environment fac<strong>to</strong>rs th<strong>at</strong> determine the overall pr<strong>of</strong>itability <strong>of</strong> an Industry,<br />

using Porter’s five forces analysis for analyzing the level <strong>of</strong> competition and business str<strong>at</strong>egy<br />

development<br />

A comprehensive list <strong>of</strong> key market players along with their product portfolio, current<br />

str<strong>at</strong>egic interests, key financial inform<strong>at</strong>ion, legal issues, SWOT analysis and analyst<br />

overview <strong>to</strong> study and sustain the market environment<br />

Competitive landscape analysis listing out the mergers, acquisitions, collabor<strong>at</strong>ions in the<br />

field along with new product launches, compar<strong>at</strong>ive financial studies and recent<br />

developments in the market <strong>by</strong> the major companies<br />

An executive summary, abridging the entire report in such a way th<strong>at</strong> decision-making<br />

personnel can rapidly <strong>be</strong>come acquainted with background inform<strong>at</strong>ion, concise analysis and<br />

main conclusions<br />

Expertly devised analyst overview along with Investment opportunities <strong>to</strong> provide both<br />

individuals and organiz<strong>at</strong>ions a strong financial foothold in the market<br />

+1 888-702-9626 | www.marketd<strong>at</strong>aforecast.com | contact@marketd<strong>at</strong>aforecast.com


ABOUT US<br />

<strong>Market</strong> D<strong>at</strong>a Forecast is a firm working in the areas <strong>of</strong> market research<br />

and business intelligence. We have rich experience in research across<br />

various business domains and we c<strong>at</strong>er <strong>to</strong> the needs <strong>of</strong> both individual<br />

and corpor<strong>at</strong>e clients. Our research services assist clients in key<br />

business areas like business process improvement, key decision<br />

making and developing appropri<strong>at</strong>e corpor<strong>at</strong>e str<strong>at</strong>egy. We are truly<br />

committed <strong>to</strong> our clients and other stakeholders for providing<br />

cus<strong>to</strong>mized research services <strong>of</strong> the highest quality.<br />

CONTACT INFORMATION<br />

We always look forward <strong>to</strong> working with new clients, pushing our<br />

boundaries and extending our reach <strong>be</strong>yond global horizons. Get in<br />

<strong>to</strong>uch with us for further queries.<br />

Website: www.marketd<strong>at</strong>aforecast.com<br />

E-Mail: contact@marketd<strong>at</strong>aforecast.com<br />

Phone: +1 888-702-9626 (U.S Toll free),<br />

+91 7680952236 (Indian Office).<br />

FOR MORE INFORMATION<br />

+1 888-702-9626 | www.marketd<strong>at</strong>aforecast.com | contact@marketd<strong>at</strong>aforecast.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!